Clin Res Cardiol (2021) DOI DOI https://doi.org/10.1007/s00392-021-01843-w |
||
T-cell subset disparity and exhaustion distinguish acute coronary syndromes with intact and ruptured fibrous cap | ||
T. Gerhardt1, Y. Abdelwahed1, G. Nelles1, P. Stapmanns1, C. Allomba1, D. Meteva1, C. Seppelt1, S. Knüppel1, A. Haghikia1, M. Joner2, N. Kränkel1, U. Landmesser1, D. Leistner1 | ||
1CC 11: Med. Klinik für Kardiologie, Charité - Universitätsmedizin Berlin, Berlin; 2Deutsches Herzzentrum München, München; | ||
Background: Rupture of atherosclerotic plaque is the most common cause of acute coronary syndrome (ACS with ruptured fibrous cap, RFC-ACS). In about one third of ACS-events, however, the causative acute pathology is plaque erosion, characterized by coronary thrombus formation at a culprit plaque with intact fibrous cap (IFC-ACS). The pathomechanism of this important pathology is largely unknown. Within the translational OPTICO-ACS study program, we recently observed significant enrichment of cytotoxic- and helper T-cells selectively at the culprit lesion site of IFC-ACS, but phenotypical and functional details of the observed T-cell response remain unknown.
Methods and results: In a delicate balance, the principal CD4+ T-helper (TH)-subsets (regulatory T-cells (Tregs, CD127lo,CD25+), TH1- (CXCR3+), TH2- (CCR4+CCR6-), TH17- (CCR4+CCR6+), TH9- (CCR4-CCR6+) and T-follicular helper (TFH, CXCR5+) cells) mediate distinct pro-inflammatory, destabilizing (e.g. TH1, TH17) or anti-inflammatory, protective (e.g. Treg, TH2) effects on coronary atherosclerosis. For in depth characterization of local adaptive immune processes in IFC- and RFC-ACS, we used a novel combination of OCT imaging, catheter-based sample acquisition and flow-cytometry in a preliminary cohort of 17 ACS patients. Pointing to a favorable immune profile in IFC-ACS, we showed markedly elevated Treg/TH1, Treg/TH17 and TH2/TH1 ratios (p ≤0.01), as well as a trend towards local Treg accumulation ((p=0.053) as % total CD4+ T-cells in whole blood aspirated from the culprit lesion site) in IFC-ACS as compared to RFC-ACS. Interestingly, cytotoxic T-cells at the culprit lesion site of IFC-, but not RFC-ACS showed enhanced (p<0.01) expression of exhaustion markers (CD8+PD1+CD57+). In RFC-ACS, in contrast, TH1 and TH17 cells were significantly enriched (p ≤0.03) and we observed selective expansion of a highly differentiated cytotoxic CD8/CD28null-subset with high effector potential despite a replicative senescence. There were no significant differences in the TH9 or TFH subsets and CD4+ memory distribution was comparable among both ACS-causing pathologies.
Summary: For the first time, this study presents detailed phenotypic and functional characterization of the CD4+ and CD8+ T-cell response in different pathophysiologies of ACS. Besides the quantitative enrichment of T-cells previously described within IFC-ACS, culprit lesions with intact fibrous cap host a favorable, Treg-dominated adaptive response as compared to a skew towards aggressive T-effector phenotypes in RFC-ACS. |
||
https://dgk.org/kongress_programme/jt2021/aV1328.html |